| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,242 |
1,135 |
$74K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,781 |
1,507 |
$68K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
810 |
771 |
$62K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,456 |
1,304 |
$58K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,183 |
1,061 |
$36K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
528 |
501 |
$24K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,090 |
968 |
$16K |
| 87807 |
|
264 |
234 |
$3K |
| 81025 |
|
469 |
417 |
$2K |
| 81002 |
|
640 |
584 |
$2K |
| 86318 |
|
63 |
62 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
20 |
19 |
$282.75 |
| 36415 |
Collection of venous blood by venipuncture |
27 |
26 |
$2.74 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
15 |
14 |
$1.96 |